about
High susceptibility to fatty liver disease in two-pore channel 2-deficient miceThe two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release from lysosomal storesSwitching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domainγ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxinsIdentifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activationIsolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.Calmodulin is a functional regulator of Cav1.4 L-type Ca2+ channelsNovel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABA(B) receptor.Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors.Kv3.1 channels stimulate adult neural precursor cell proliferation and neuronal differentiation.Identification of clinically actionable variants from genome sequencing of families with congenital heart diseaseA Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome DataNAD deficiency due to environmental factors or gene-environment interactions causes congenital malformations and miscarriage in mice
P50
Q28246421-BFF62F20-89DD-41BF-8DAD-99A5B2E7FCA4Q28585336-8F811B65-E626-4840-82E8-191ADEEA30F1Q35108379-E0BDA5E8-5D12-4B72-A023-4ECAD9CEE7B4Q36078883-9773A9D4-E27E-42B5-9F62-F941CF6BD06EQ37348886-23F8EC7E-57CB-49D0-9A2E-99BFC0C2022CQ37677444-9A838F20-C51B-4F81-BEEC-E746A4EAD5F7Q39113921-A5EAEBB9-0DA1-43D1-808C-62DDAFD1B90CQ39287268-37B320E8-8D26-4CB5-8B98-B9E9F512F589Q39373447-22A8EE81-7BA1-4D8E-B423-6BFB00E79F26Q39806331-205E1AD4-731D-441B-98AA-9F36E265E080Q45111341-E9CF93C1-CC88-4460-943D-D808220183A7Q46659542-6F39F55D-6A2F-4B96-8716-D87CCAC27B8BQ50483041-12118BB5-2924-45DE-B337-E85B9EDAA23DQ57180807-5C4E17B6-41F6-4E52-A1B5-01627AF85210Q59164823-763E9BAB-43F6-4E17-996E-CE23DA568A56Q89517772-9F1C3095-9D18-40AE-8C0A-B5932CB6BEBA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hartmut Cuny
@ast
Hartmut Cuny
@en
Hartmut Cuny
@es
Hartmut Cuny
@nl
type
label
Hartmut Cuny
@ast
Hartmut Cuny
@en
Hartmut Cuny
@es
Hartmut Cuny
@nl
prefLabel
Hartmut Cuny
@ast
Hartmut Cuny
@en
Hartmut Cuny
@es
Hartmut Cuny
@nl
P106
P1153
15043847600
P31
P496
0000-0002-1551-2354